Monthly Archives: January 2015

Biopharmaceutical News week 4 2015

    Acquisitions /mergers/joint-ventures   January 16, 2015 Roche acquires Trophos and boosts its neuromuscular drug pipeline Roche agreed to pay as much as $543 million to purchase Trophos, a Marseille (France) -based company funded by the French Muscular Dystrophy Association. The deal will give Roche access to Trophos' pipeline of neuromuscular disease drugs including […]

read more

Biopharmaceutical News Week 2 2014

    Acquisitions /mergers/joint-ventures   January 2, 2015 Cardio3 buys OnCyte oncology unit Celdara Medical (USA) agreed to sell its oncology unit OnCyte to Cardio3 Biosciences (Belgium) for $182 million. The OnCyte pipeline includes three autologous Chimeric Antigen Receptor (CAR) T cell treatments and an allogenic T cell technology.   January 5, 2015 NPS Pharma […]

read more

Biopharmaceutical News Highlights 2014

2014 a highly successful year for the biopharmaceutical industry     In terms of New Drug Approvals Both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have reported an exceptional high level of drug approvals in 2014. The FDA has approved 41 new Molecular Entities (NMEs) and Biological License Applications […]

read more